Hetero launches generic breast cancer treatment drug in India
Drug firm Hetero Friday said it has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in the country.
Intas settles patent litigation with Hoffmann-La Roche for capecitabine tablet
Ahmedabad-based drug maker, Intas Pharmaceuticals Ltd and its ...
Cipla arm secures marketing rights for cancer drug in US
Cipla USA, Inc, a subsidiary of the company will be marketing the drug in strengths ...
Smallcap Hunters: API plans make Shivalik Rasayan valuations look very compelling
The company’s core business of pesticides has steadily been doing around Rs 50 crore sales.
Divi’s Laboratories nosedives 20%, hits 52-week low on USFDA’s import alert
In a filing to BSE, the drug marker said that the USFDA has exempted the company from making ten drugs.
Dr Reddy's in bear grip on adverse USFDA report, stock may fall 7-8%
Open interest in Dr Reddy's futures rose 16% as short positions were built and was the highest since July 2007, while in the cash market, the stock hit a 31-month low.
Government panel moots clinical trial waiver for two cancer drugs
The two medicines - Aflibercept and Trastuzumab emtansine - are used in treatment of metastatic colorectal cancer and metastatic breast cancer respectively.
NPPA invites comments on Tata Memorial list of cancer drugs
"(this is) on revision of NLEM 2011 with respect to addition/ deletion of drugs relating to oncology from price control and affordability angle."
Shilpa Medicare receives EU GMP approval from Germany
Pharma company Shilpa Medicare on Friday said it has received European Union GMP approval from Germany for two of its manufacturing sites for production of cancer drugs.